Tocqueville Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Tocqueville Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,141	Closed	-$440K	–	612
2022 Q3	$440K	Buy	4,141 +66	+2%	+$7.01K	0.01%	461
2022 Q2	$397K	Hold	4,075	–	–	0.01%	532
2022 Q1	$382K	Hold	4,075	–	–	0.01%	566
2021 Q4	$347K	Hold	4,075	–	–	﹤0.01%	619
2021 Q3	$391K	Sell	4,075 -3,525	-46%	-$338K	0.01%	583
2021 Q2	$740K	Sell	7,600 -73	-1%	-$7.11K	0.01%	491
2021 Q1	$746K	Hold	7,673	–	–	0.01%	489
2020 Q4	$735K	Sell	7,673 -102	-1%	-$9.77K	0.01%	483
2020 Q3	$748K	Sell	7,775 -49	-0.6%	-$4.71K	0.01%	433
2020 Q2	$955K	Buy	7,824 +124	+2%	+$15.1K	0.02%	397
2020 Q1	$666K	Sell	7,700 -2,500	-25%	-$216K	0.02%	408
2019 Q4	$1.1M	Sell	10,200 -9,055	-47%	-$973K	0.02%	440
2019 Q3	$1.74M	Buy	19,255 +4,500	+30%	+$405K	0.02%	387
2019 Q2	$1.25M	Sell	14,755 -1,829	-11%	-$154K	0.02%	446
2019 Q1	$1.46M	Sell	16,584 -1,616	-9%	-$142K	0.02%	422
2018 Q4	$1.3M	Sell	18,200 -4,375	-19%	-$313K	0.02%	428
2018 Q3	$2.78M	Buy	22,575 +3,500	+18%	+$430K	0.04%	375
2018 Q2	$1.87M	Buy	19,075 +1,500	+9%	+$147K	0.02%	431
2018 Q1	$1.46M	Buy	17,575 +50	+0.3%	+$4.15K	0.02%	465
2017 Q4	$1.36M	Hold	17,525	–	–	0.02%	473
2017 Q3	$1.07M	Hold	17,525	–	–	0.01%	519
2017 Q2	$806K	Sell	17,525 -2,500	-12%	-$115K	0.01%	526
2017 Q1	$867K	Sell	20,025 -4,600	-19%	-$199K	0.01%	511
2016 Q4	$953K	Sell	24,625 -9,100	-27%	-$352K	0.01%	497
2016 Q3	$1.71M	Sell	33,725 -9,175	-21%	-$465K	0.02%	427
2016 Q2	$1.95M	Buy	42,900 +1,800	+4%	+$81.8K	0.02%	416
2016 Q1	$1.63M	Buy	41,100 +15,900	+63%	+$629K	0.02%	425
2015 Q4	$1.43M	Buy	25,200 +4,000	+19%	+$226K	0.02%	475
2015 Q3	$844K	Buy	21,200 +8,000	+61%	+$318K	0.01%	594
2015 Q2	$630K	Buy	+13,200	New	+$630K	0.01%	659
2013 Q4	–	Sell	-23,350	Closed	-$264K	–	1396
2013 Q3	$264K	Hold	23,350	–	–	﹤0.01%	812
2013 Q2	$312K	Buy	+23,350	New	+$312K	﹤0.01%	768